AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Silence Therapeutics plc

Net Asset Value • Oct 23, 2013

33536_rns_2013-10-23_993ce849-4196-4760-8aac-833bd13c050a.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1040R

Silence Therapeutics PLC

23 October 2013

INVESTOR EVENT

On Monday 18th November 2013, Silence Therapeutics is hosting an Investor event for investors and analysts in London. The purpose of the event is to explain the background to Silence's technology and outline its potential. No material new information will be presented.

For further information please contact:

Silence Therapeutics plc

Timothy Freeborn, finance director

Annie Cheng, director of corporate development

+44 (0)333 988 0140

[email protected]

N+1 Singer

Shaun Dobson/Jenny Wyllie

+44 20 7496 3000

[email protected]

This information is provided by RNS

The company news service from the London Stock Exchange